Global Sofosbuvir (CAS 1190307-88-0) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 76387
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Chemical and Material
Buy @ $3500

The Sofosbuvir (CAS 1190307-88-0) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Sofosbuvir (CAS 1190307-88-0) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Sofosbuvir (CAS 1190307-88-0) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Sofosbuvir (CAS 1190307-88-0) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Purity ≥ 98%

Purity ＜ 98%

Market segment by Application can be divided into

Adults Patients

Elderly Patients

The key market players for global Sofosbuvir (CAS 1190307-88-0) market are listed below:

Teva Pharmaceutical Industries Ltd

DONG BANG FUTURE TECH & LIFE CO., LTD

Beaukev Pharma International Pvt.Ltd

DEAFARMA

Tecoland

Anhui HaiKang Pharmaceutical Co. Ltd

Shanghai Haoyuan Chemexpress Co., Ltd

Beijing Kawin Technology Share-holding Co

Hangzhou Longshine Bio-Tech Co

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Sofosbuvir (CAS 1190307-88-0) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Sofosbuvir (CAS 1190307-88-0), with price, sales, revenue and global market share of Sofosbuvir (CAS 1190307-88-0) in 2018 and 2019.

Chapter 3, the Sofosbuvir (CAS 1190307-88-0) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Sofosbuvir (CAS 1190307-88-0) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Sofosbuvir (CAS 1190307-88-0) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Sofosbuvir (CAS 1190307-88-0) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Sofosbuvir (CAS 1190307-88-0) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Purity ≥ 98%

1.2.3 Purity ＜ 98%

1.3 Market Analysis by Application

1.3.1 Overview: Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Adults Patients

1.3.3 Elderly Patients

1.4 Global Sofosbuvir (CAS 1190307-88-0) Market Size & Forecast

1.4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Value (2016-2026))

1.4.2 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume (2016-2026)

1.4.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2026) & (USD/MT)

1.5 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity Analysis

1.5.1 Global Sofosbuvir (CAS 1190307-88-0) Total Production Capacity (2016-2026)

1.5.2 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Sofosbuvir (CAS 1190307-88-0) Market Drivers

1.6.2 Sofosbuvir (CAS 1190307-88-0) Market Restraints

1.6.3 Sofosbuvir (CAS 1190307-88-0) Trends Analysis

2 Manufacturers Profiles

2.1 Teva Pharmaceutical Industries Ltd

2.1.1 Teva Pharmaceutical Industries Ltd Details

2.1.2 Teva Pharmaceutical Industries Ltd Major Business

2.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

2.1.4 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 DONG BANG FUTURE TECH & LIFE CO., LTD

2.2.1 DONG BANG FUTURE TECH & LIFE CO., LTD Details

2.2.2 DONG BANG FUTURE TECH & LIFE CO., LTD Major Business

2.2.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product and Services

2.2.4 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Beaukev Pharma International Pvt.Ltd

2.3.1 Beaukev Pharma International Pvt.Ltd Details

2.3.2 Beaukev Pharma International Pvt.Ltd Major Business

2.3.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

2.3.4 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 DEAFARMA

2.4.1 DEAFARMA Details

2.4.2 DEAFARMA Major Business

2.4.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Services

2.4.4 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Tecoland

2.5.1 Tecoland Details

2.5.2 Tecoland Major Business

2.5.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Services

2.5.4 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Anhui HaiKang Pharmaceutical Co. Ltd

2.6.1 Anhui HaiKang Pharmaceutical Co. Ltd Details

2.6.2 Anhui HaiKang Pharmaceutical Co. Ltd Major Business

2.6.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

2.6.4 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Shanghai Haoyuan Chemexpress Co., Ltd

2.7.1 Shanghai Haoyuan Chemexpress Co., Ltd Details

2.7.2 Shanghai Haoyuan Chemexpress Co., Ltd Major Business

2.7.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

2.7.4 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Beijing Kawin Technology Share-holding Co

2.8.1 Beijing Kawin Technology Share-holding Co Details

2.8.2 Beijing Kawin Technology Share-holding Co Major Business

2.8.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Services

2.8.4 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Hangzhou Longshine Bio-Tech Co

2.9.1 Hangzhou Longshine Bio-Tech Co Details

2.9.2 Hangzhou Longshine Bio-Tech Co Major Business

2.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Services

2.9.4 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturer

3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Sofosbuvir (CAS 1190307-88-0)

3.4 Market Concentration Rate

3.4.1 Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share

3.4.2 Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share

3.5 Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Sofosbuvir (CAS 1190307-88-0) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Sofosbuvir (CAS 1190307-88-0) Market Size by Region

4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Region (2016-2026)

4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2016-2026)

4.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026)

4.3 Europe Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026)

4.4 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026)

4.5 South America Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026)

4.6 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Type (2016-2026)

5.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2016-2026)

5.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Application (2016-2026)

6.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2016-2026)

6.3 Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2026)

7.2 North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2026)

7.3 North America Sofosbuvir (CAS 1190307-88-0) Market Size by Country

7.3.1 North America Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2016-2026)

7.3.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2026)

8.2 Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2026)

8.3 Europe Sofosbuvir (CAS 1190307-88-0) Market Size by Country

8.3.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2016-2026)

8.3.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2026)

9.2 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2026)

9.3 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Market Size by Region

9.3.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2026)

10.2 South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2026)

10.3 South America Sofosbuvir (CAS 1190307-88-0) Market Size by Country

10.3.1 South America Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2016-2026)

10.3.2 South America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2026)

11.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2026)

11.3 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Market Size by Country

11.3.1 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Sofosbuvir (CAS 1190307-88-0) Typical Distributors

12.3 Sofosbuvir (CAS 1190307-88-0) Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type, (USD Million), 2021-2026

Table 2. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application, (USD Million), 2021-2026

Table 3. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors

Table 4. Teva Pharmaceutical Industries Ltd Major Business

Table 5. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 6. Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. DONG BANG FUTURE TECH & LIFE CO., LTD Basic Information, Manufacturing Base and Competitors

Table 8. DONG BANG FUTURE TECH & LIFE CO., LTD Major Business

Table 9. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 10. DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Beaukev Pharma International Pvt.Ltd Basic Information, Manufacturing Base and Competitors

Table 12. Beaukev Pharma International Pvt.Ltd Major Business

Table 13. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 14. Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. DEAFARMA Basic Information, Manufacturing Base and Competitors

Table 16. DEAFARMA Major Business

Table 17. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 18. DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Tecoland Basic Information, Manufacturing Base and Competitors

Table 20. Tecoland Major Business

Table 21. Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 22. Tecoland Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Anhui HaiKang Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors

Table 24. Anhui HaiKang Pharmaceutical Co. Ltd Major Business

Table 25. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 26. Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Shanghai Haoyuan Chemexpress Co., Ltd Basic Information, Manufacturing Base and Competitors

Table 28. Shanghai Haoyuan Chemexpress Co., Ltd Major Business

Table 29. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 30. Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Beijing Kawin Technology Share-holding Co Basic Information, Manufacturing Base and Competitors

Table 32. Beijing Kawin Technology Share-holding Co Major Business

Table 33. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 34. Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Hangzhou Longshine Bio-Tech Co Basic Information, Manufacturing Base and Competitors

Table 36. Hangzhou Longshine Bio-Tech Co Major Business

Table 37. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Services

Table 38. Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Global Sofosbuvir (CAS 1190307-88-0) Sales by Manufacturer (2019-2021e) & (MT)

Table 40. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 41. Market Position of Manufacturers in Sofosbuvir (CAS 1190307-88-0), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 42. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Company, (MT): 2020 VS 2021

Table 43. Head Office and Sofosbuvir (CAS 1190307-88-0) Production Site of Key Manufacturer

Table 44. Sofosbuvir (CAS 1190307-88-0) New Entrant and Capacity Expansion Plans

Table 45. Sofosbuvir (CAS 1190307-88-0) Mergers & Acquisitions in the Past Five Years

Table 46. Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2016-2021e) & (MT)

Table 47. Global Sofosbuvir (CAS 1190307-88-0) Sales by Region (2021-2026) & (MT)

Table 48. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2016-2021e) & (USD Million)

Table 49. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2021-2026) & (USD Million)

Table 50. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2021e) & (MT)

Table 51. Global Sofosbuvir (CAS 1190307-88-0) Sales by Type (2021-2026) & (MT)

Table 52. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2016-2021e) & (USD Million)

Table 53. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Type (2021-2026) & (USD Million)

Table 54. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2021e) & (USD/MT)

Table 55. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2021-2026) & (USD/MT)

Table 56. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2021e) & (MT)

Table 57. Global Sofosbuvir (CAS 1190307-88-0) Sales by Application (2021-2026) & (MT)

Table 58. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2016-2021e) & (USD Million)

Table 59. Global Sofosbuvir (CAS 1190307-88-0) Revenue by Application (2021-2026) & (USD Million)

Table 60. Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2016-2021e) & (USD/MT)

Table 61. Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2021-2026) & (USD/MT)

Table 62. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2016-2021e) & (MT)

Table 63. North America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2021-2026) & (MT)

Table 64. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2021e) & (USD Million)

Table 65. North America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2021-2026) & (USD Million)

Table 66. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2021e) & (MT)

Table 67. North America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2021-2026) & (MT)

Table 68. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2021e) & (MT)

Table 69. North America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2021-2026) & (MT)

Table 70. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2016-2021e) & (MT)

Table 71. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Country (2021-2026) & (MT)

Table 72. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2021e) & (USD Million)

Table 73. Europe Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2021-2026) & (USD Million)

Table 74. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2021e) & (MT)

Table 75. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Type (2021-2026) & (MT)

Table 76. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2021e) & (MT)

Table 77. Europe Sofosbuvir (CAS 1190307-88-0) Sales by Application (2021-2026) & (MT)

Table 78. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2016-2021e) & (MT)

Table 79. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Region (2021-2026) & (MT)

Table 80. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2016-2021e) & (USD Million)

Table 81. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue by Region (2021-2026) & (USD Million)

Table 82. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2021e) & (MT)

Table 83. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Type (2021-2026) & (MT)

Table 84. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2021e) & (MT)

Table 85. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales by Application (2021-2026) & (MT)

Table 86. South America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2016-2021e) & (MT)

Table 87. South America Sofosbuvir (CAS 1190307-88-0) Sales by Country (2021-2026) & (MT)

Table 88. South America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2021e) & (USD Million)

Table 89. South America Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2021-2026) & (USD Million)

Table 90. South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2021e) & (MT)

Table 91. South America Sofosbuvir (CAS 1190307-88-0) Sales by Type (2021-2026) & (MT)

Table 92. South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2021e) & (MT)

Table 93. South America Sofosbuvir (CAS 1190307-88-0) Sales by Application (2021-2026) & (MT)

Table 94. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2016-2021e) & (MT)

Table 95. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Country (2021-2026) & (MT)

Table 96. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2016-2021e) & (USD Million)

Table 97. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue by Country (2021-2026) & (USD Million)

Table 98. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2016-2021e) & (MT)

Table 99. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Type (2021-2026) & (MT)

Table 100. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2016-2021e) & (MT)

Table 101. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales by Application (2021-2026) & (MT)

Table 102. Direct Channel Pros & Cons

Table 103. Indirect Channel Pros & Cons

Table 104. Sofosbuvir (CAS 1190307-88-0) Typical Distributors

Table 105. Sofosbuvir (CAS 1190307-88-0) Typical Customers

List of Figures

Figure 1. Sofosbuvir (CAS 1190307-88-0) Picture

Figure 2. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type in 2020

Figure 3. Purity ≥ 98%

Figure 4. Purity ＜ 98%

Figure 5. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application in 2020

Figure 6. Adults Patients

Figure 7. Elderly Patients

Figure 8. Global Sofosbuvir (CAS 1190307-88-0) Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026

Figure 9. Global Sofosbuvir (CAS 1190307-88-0) Market Size and Forecast (2016-2026) & (USD Million)

Figure 10. Global Sofosbuvir (CAS 1190307-88-0) Sales (2016-2026) & (MT)

Figure 11. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2026) & (USD/MT)

Figure 12. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity (2016-2026) & (MT)

Figure 13. Global Sofosbuvir (CAS 1190307-88-0) Production Capacity by Geographic Region: 2020 VS 2021

Figure 14. Sofosbuvir (CAS 1190307-88-0) Market Drivers

Figure 15. Sofosbuvir (CAS 1190307-88-0) Market Restraints

Figure 16. Sofosbuvir (CAS 1190307-88-0) Market Trends

Figure 17. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Manufacturer in 2020

Figure 18. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Manufacturer in 2020

Figure 19. Sofosbuvir (CAS 1190307-88-0) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2020

Figure 21. Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer (Revenue) Market Share in 2020

Figure 22. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2016-2026)

Figure 23. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2016-2026)

Figure 24. North America Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026) & (USD Million)

Figure 25. Europe Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026) & (USD Million)

Figure 26. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026) & (USD Million)

Figure 27. South America Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026) & (USD Million)

Figure 28. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue (2016-2026) & (USD Million)

Figure 29. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2016-2026)

Figure 30. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Type (2016-2026)

Figure 31. Global Sofosbuvir (CAS 1190307-88-0) Price by Type (2016-2026) & (USD/MT)

Figure 32. Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2026)

Figure 33. Global Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Application (2016-2026)

Figure 34. Global Sofosbuvir (CAS 1190307-88-0) Price by Application (2016-2026) & (USD/MT)

Figure 35. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2016-2026)

Figure 36. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2026)

Figure 37. North America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2016-2026)

Figure 38. North America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2016-2026)

Figure 39. United States Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 40. Canada Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Mexico Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2016-2026)

Figure 43. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2026)

Figure 44. Europe Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2016-2026)

Figure 45. Europe Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2016-2026)

Figure 46. Germany Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. France Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. United Kingdom Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Russia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Italy Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2016-2026)

Figure 52. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2026)

Figure 53. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Region (2016-2026)

Figure 55. China Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Japan Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Korea Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. India Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Southeast Asia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Australia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2016-2026)

Figure 62. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2026)

Figure 63. South America Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2016-2026)

Figure 64. South America Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2016-2026)

Figure 65. Brazil Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Argentina Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Type (2016-2026)

Figure 68. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2016-2026)

Figure 69. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Country (2016-2026)

Figure 70. Middle East & Africa Sofosbuvir (CAS 1190307-88-0) Revenue Market Share by Country (2016-2026)

Figure 71. Turkey Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Egypt Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South Africa Sofosbuvir (CAS 1190307-88-0) Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Sales Channel: Direct Channel vs Indirect Channel

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz